Home › Funds › Institute for Wealth Management, LLC. › VKTX
Institute for Wealth Management, LLC. position in VKTX
VIKING THERAPEUTICS INC · Health Care
Institute for Wealth Management, LLC. reported holding 108,643 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.39% of its reported portfolio and ranking #50 among its reported holdings. Institute for Wealth Management, LLC. has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Institute for Wealth Management, LLC.'s VKTX position evolved
Institute for Wealth Management, LLC. first disclosed a stake in VKTX in Q3 2023 at 11,880 shares (US$132K). The position peaked in Q2 2026 at 108,643 shares, worth US$4.2M. Across 12 filings, Institute for Wealth Management, LLC. increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 108,643 shares valued at US$4.2M. Notable position changes include a 272% increase in Q2 2024 (shares rose 19% over the following quarter), a 122% increase in Q4 2024 (shares fell 40% over the following quarter), a 26878% increase in Q4 2025 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 11.88K | $131.51K | New |
| Q4 2023 | 11.88K | $221.09K | Hold |
| Q1 2024 | 8.58K | $703.56K | Reduce |
| Q2 2024 | 31.92K | $1.69M | Add |
| Q3 2024 | 36.24K | $2.29M | Add |
| Q4 2024 | 80.60K | $3.24M | Add |
| Q1 2025 | 90.34K | $2.18M | Add |
| Q2 2025 | 90.38K | $2.39M | Hold |
| Q3 2025 | 400 | $10.51K | Reduce |
| Q4 2025 | 107.91K | $3.80M | Add |
| Q1 2026 | 108.70K | $3.54M | Add |
| Q2 2026 | 108.64K | $4.24M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VKTX and 13F data
VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VKTX
- Vestal Point Capital, LP 680.00K sh · $26.53M · Q2 2026
- Eversept Partners, LP 602.92K sh · $23.52M · Q2 2026
- ADAR1 Capital Management, LLC 574.04K sh · $22.39M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 500.00K sh · $19.50M · Q2 2026
More on Institute for Wealth Management, LLC.
FAQ
How long has Institute for Wealth Management, LLC. held VKTX?
Institute for Wealth Management, LLC. has disclosed VKTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Institute for Wealth Management, LLC.'s current position in VKTX?
As of Q2 2026, Institute for Wealth Management, LLC. holds 108.64K shares of VKTX (VIKING THERAPEUTICS INC), valued at $4.24M, representing 0.39% of its reported portfolio and ranking #50.
Has Institute for Wealth Management, LLC. been buying or selling VKTX?
In the latest 13F filing (Q2 2026), Institute for Wealth Management, LLC. held unchanged its position in VKTX. The position peaked in Q2 2026 at 108.64K shares.
Which other funds hold VKTX?
Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.